MANUFACTURERS LIFE INSURANCE COMPANY, THE - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 89 filers reported holding RECRO PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q1 2020$2,288,000
-37.1%
280,114
+41.2%
0.00%
-25.0%
Q4 2019$3,635,000
-49.7%
198,315
-69.1%
0.00%
-50.0%
Q3 2019$7,230,000
+10.4%
642,122
-0.2%
0.01%0.0%
Q2 2019$6,547,000
+84.6%
643,721
+6.3%
0.01%
+100.0%
Q1 2019$3,547,000
+86.5%
605,301
+126.0%
0.00%
+100.0%
Q4 2018$1,902,000
-38.3%
267,833
-38.3%
0.00%
-33.3%
Q3 2018$3,085,000
+108.6%
433,933
+47.3%
0.00%
+50.0%
Q2 2018$1,479,000
-43.0%
294,599
+25.0%
0.00%
-33.3%
Q1 2018$2,595,000
+7532.4%
235,712
+6480.5%
0.00%
Q4 2017$34,000
+3300.0%
3,582
+2458.6%
0.00%
Q3 2017$1,0000.0%140
+12.9%
0.00%
Q2 2017$1,0000.0%124
+7.8%
0.00%
Q1 2017$1,0000.0%1150.0%0.00%
Q4 2016$1,0000.0%1150.0%0.00%
Q3 2016$1,000
-83.3%
115
-85.9%
0.00%
Q2 2016$6,000
+20.0%
8140.0%0.00%
Q1 2016$5,000
-16.7%
814
+16.5%
0.00%
Q4 2015$6,000
-25.0%
6990.0%0.00%
Q3 2015$8,000
-11.1%
6990.0%0.00%
Q2 2015$9,0006990.00%
Other shareholders
RECRO PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Engine Capital Management, LP 872,494$6,195,0003.64%
Newtyn Management, LLC 1,600,000$11,360,0002.22%
Broadfin Capital, LLC 2,048,025$14,541,0001.91%
Balter Liquid Alternatives, LLC 92,167$654,0000.45%
ESSEX INVESTMENT MANAGEMENT CO LLC 515,414$3,660,0000.29%
JT Stratford LLC 45,367$322,0000.21%
Opus Point Partners Management, LLC 11,353$81,0000.18%
Alyeska Investment Group, L.P. 964,000$6,844,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 500,625$3,554,0000.09%
Monarch Partners Asset Management LLC 55,857$397,0000.06%
View complete list of RECRO PHARMA INC shareholders